Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 153

1.

Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation.

Gilan O, Rioja I, Knezevic K, Bell MJ, Yeung MM, Harker NR, Lam EYN, Chung CW, Bamborough P, Petretich M, Urh M, Atkinson SJ, Bassil AK, Roberts EJ, Vassiliadis D, Burr ML, Preston AGS, Wellaway C, Werner T, Gray JR, Michon AM, Gobbetti T, Kumar V, Soden PE, Haynes A, Vappiani J, Tough DF, Taylor S, Dawson SJ, Bantscheff M, Lindon M, Drewes G, Demont EH, Daniels DL, Grandi P, Prinjha RK, Dawson MA.

Science. 2020 Mar 19. pii: eaaz8455. doi: 10.1126/science.aaz8455. [Epub ahead of print]

PMID:
32193360
2.

Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.

Auluck I, Karimi A, Taylor S.

Clin Med (Lond). 2019 Nov;19(6):519-522. doi: 10.7861/clinmed.2019.0149.

3.

Lesson of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.

Auluck I, Karimi A, Taylor S.

Clin Med (Lond). 2019 Oct 22. pii: clinmed.2019-0149. doi: 10.7861/clinmed.2019-0149. [Epub ahead of print]

PMID:
31641065
4.

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.

Hykin P, Prevost AT, Vasconcelos JC, Murphy C, Kelly J, Ramu J, Hounsome B, Yang Y, Harding SP, Lotery A, Chakravarthy U, Sivaprasad S; LEAVO Study Group.

JAMA Ophthalmol. 2019 Aug 29. doi: 10.1001/jamaophthalmol.2019.3305. [Epub ahead of print]

5.

Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment.

Wilcockson TDW, Mardanbegi D, Xia B, Taylor S, Sawyer P, Gellersen HW, Leroi I, Killick R, Crawford TJ.

Aging (Albany NY). 2019 Aug 2;11(15):5389-5398. doi: 10.18632/aging.102118. Epub 2019 Aug 2.

6.

Towards an exposure narrative for metals and arsenic in historically contaminated Ni refinery soils: Relationships between speciation, bioavailability, and bioaccessibility.

Dutton MD, Vasiluk L, Ford F, Bellantino Perco M, Taylor SR, Lopez K, Bolger GT, Gopalapillai Y, Hale B.

Sci Total Environ. 2019 Oct 10;686:805-818. doi: 10.1016/j.scitotenv.2019.05.164. Epub 2019 May 16.

7.

Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study.

Garweg JG, Stefanickova J, Hoyng C, Schmelter T, Niesen T, Sowade O, Sivaprasad S; AQUA Investigators.

Ophthalmol Retina. 2019 Jul;3(7):567-575. doi: 10.1016/j.oret.2019.03.012. Epub 2019 Mar 21.

PMID:
31080168
8.

Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health.

Ogunleye OO, Fadare JO, Eriksen J, Oaiya O, Massele A, Truter I, Taylor SJE, Godman B, Gustafsson LL.

Expert Rev Clin Pharmacol. 2019 May;12(5):481-489. doi: 10.1080/17512433.2019.1605903. Epub 2019 Apr 27.

PMID:
30961406
9.

Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.

Karatsai E, Robson AG, Taylor SRJ.

JAMA Ophthalmol. 2019 May 1;137(5):564-567. doi: 10.1001/jamaophthalmol.2019.0284.

10.

Repeatability and accuracy of a foot muscle strength dynamometer.

Garofolini A, Taylor S, McLaughlin P, Stokes R, Kusel M, Mickle KJ.

Med Eng Phys. 2019 May;67:102-108. doi: 10.1016/j.medengphy.2019.03.005. Epub 2019 Mar 9.

PMID:
30857935
11.

The effect of running on foot muscles and bones: A systematic review.

Garofolini A, Taylor S.

Hum Mov Sci. 2019 Apr;64:75-88. doi: 10.1016/j.humov.2019.01.006. Epub 2019 Jan 22.

PMID:
30682645
12.

Evaluating dynamic error of a treadmill and the effect on measured kinetic gait parameters: Implications and possible solutions.

Garofolini A, Taylor S, Lepine J.

J Biomech. 2019 Jan 3;82:156-163. doi: 10.1016/j.jbiomech.2018.10.025. Epub 2018 Oct 27.

PMID:
30392776
13.

Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries.

Chakravarthy U, Taylor SR, Koch FHJ, Castro de Sousa JP, Bailey C; ILUVIEN Registry Safety Study (IRISS) Investigators Group.

Br J Ophthalmol. 2019 Aug;103(8):1072-1077. doi: 10.1136/bjophthalmol-2018-312284. Epub 2018 Sep 21.

14.

Applicability of Mechanical Tests for Biomass Pellet Characterisation for Bioenergy Applications.

Williams O, Taylor S, Lester E, Kingman S, Giddings D, Eastwick C.

Materials (Basel). 2018 Jul 31;11(8). pii: E1329. doi: 10.3390/ma11081329.

15.

Glycemic control is an important modifiable risk factor for uveitis in patients with diabetes: A retrospective cohort study establishing clinical risk and ophthalmic disease burden.

Ansari AS, de Lusignan S, Hinton W, Munro N, Taylor S, McGovern A.

J Diabetes Complications. 2018 Jun;32(6):602-608. doi: 10.1016/j.jdiacomp.2018.03.008. Epub 2018 Mar 23.

PMID:
29656910
16.

BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.

Morse MA, Balogh KK, Brendle SA, Campbell CA, Chen MX, Furze RC, Harada IL, Holyer ID, Kumar U, Lee K, Prinjha RK, Rüdiger M, Seal JT, Taylor S, Witherington J, Christensen ND.

Antiviral Res. 2018 Jun;154:158-165. doi: 10.1016/j.antiviral.2018.03.012. Epub 2018 Apr 11.

17.

The Allergen Bureau VITAL Program.

Taylor SB, Christensen G, Grinter K, Sherlock R, Warren L.

J AOAC Int. 2018 Jan 1;101(1):77-82. doi: 10.5740/jaoacint.17-0392. Epub 2017 Dec 5.

18.

Ocular Features of Cerebro-Costo-Mandibular Syndrome.

Hameed Z, Taylor S, Lindfield D.

J Glaucoma. 2018 Jan;27(1):e21-e23. doi: 10.1097/IJG.0000000000000815.

PMID:
29117007
19.

BET 1: Prednisolone for the treatment of acute gouty arthritis.

Simon Taylor R.

Emerg Med J. 2017 Oct;34(10):687-689. doi: 10.1136/emermed-2017-207129.1. Review.

PMID:
28963379
20.

In reply.

Taylor DM, Yap CYL, Kong DCM, Knott JC, Taylor SE, Phillips GA, Karro J, Chan EW, Castle DJ.

Ann Emerg Med. 2017 Apr;69(4):521-523. doi: 10.1016/j.annemergmed.2016.11.029. No abstract available.

PMID:
28335925

Supplemental Content

Loading ...
Support Center